RPS launch consultant pharmacist credentialing


The Royal Pharmaceutical Society (RPS) has launched consultant pharmacist credentialing to allow advanced-level practitioners to demonstrate they have the knowledge, skills, behaviours and experience required to apply for approved consultant pharmacist posts.

The programme’s curriculum sets out the knowledge, skills, behaviours and performance levels expected in five areas:

  • Professional practice.
  • Communication and collaborative working.
  • Leadership and management.
  • Education.
  • Research.


Pharmacists can work towards the curriculum outcomes by compiling an electronic portfolio to demonstrate their learning in collaboration with a professional coach and expert mentors. This forms the basis of the assessment, which is carried out by an expert committee.

Once approved, the practitioner is credentialed as ‘consultant-ready’ and is eligible to take up approved consultant pharmacist posts.

RPS Director of Education Gail Fleming said:

“Consultants are critical to the development and success of clinical care pathways across systems in their area of clinical practice. We want to see a greater number of consultant pharmacists in post providing clinical expertise and leadership across local health economies. They have an important role in the delivery of ever more complex care to patients and in supporting their colleagues.

“We have already developed a national approval process for consultant posts, so credentialing individuals is the logical next step in building clinical excellence and leadership in the workforce.

“Our credentialing programme is now open and I encourage advanced practitioners to take the next step in their career and credential as ‘consultant-ready’.”


The launch of the new service was welcomed in Scotland. Professor Anne Watson, NES’s Postgraduate Pharmacy Dean, said:


“The RPS’s new credentialing service will provide a consistent approach – ensuring credentialed practitioners have the correct knowledge, skills, behaviours and experience. It will ensure the right people take up approved consultant pharmacist posts. In Scotland, it will support the ambitious plans for pharmacists as medicine experts – as well as the changing demands of the profession.”


Have your say by writing to the editor of Pharmacy in Practice. With your permission, we will publish your contribution.





What does the pandemic teach us about the future of antibiotics?

Stephen Hughes MBA, MSc, MPharm, Consultant Antimicrobial Pharmacist at Chelsea & Westminster NHS Foundation Trust.


Stephen Hughes MBA, MSc, MPharm, is a consultant antimicrobial pharmacist at Chelsea & Westminster NHS Foundation Trust. We were lucky enough to catch up with him on the podcast to discuss how he and his team have adapted to working life during the pandemic. We also discussed antimicrobial pharmacy at length. A fascinating conversation.


In your view what is the importance of patient-reported outcomes in antibiotic use?


How do we innovate before we have to in the antibiotic space?


Are we too reliant on the pharmaceutical industry to keep coming up with new antibiotics and how sustainable is this cycle?


Do we make the best use of new antibiotics?


How should the UK government intervene to ensure a robust pipeline of new antibiotics remains into the future?


Are we collectively being too complacent in the prescribing practise that we tolerate with antibiotics?


What have you and your team had to unlearn during COVID-19?


Are you concerned about a surge of secondary bacterial infection in people who have suffered COVID-19?


How have your team coped with the COVID-19 situation?



If you prefer to never miss an episode you can subscribe on your preferred podcast platform. Just click on the links below to get going.


AnchoriTunesGoogle PodcastsSpotifyBreakerOvercastPocketCastsRadio PublicPodbeanStitcher